CHICAGO — A Fas inhibitor showed strong efficacy signals and demonstrated in patients with more than 8 days of macula-off rhegmatogenous retinal detachment, according to a study. A Fas inhibitor ...
ANN ARBOR, Mich., Aug. 28, 2023 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal ...
OT learns how teamwork played a key role in the timely identification of a retinal detachment at Eyeglass Opticians ...
ANN ARBOR, Mich., April 12, 2023 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal ...
Patients may experience better visual acuity if the duration of macular detachment is shortened to 3 days or less, according to a study conducted by the Department of Ophthalmology at Horngren Family ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback